Pulse Biosciences Inc
NASDAQ:PLSE
Pulse Biosciences Inc
Free Cash Flow
Pulse Biosciences Inc
Free Cash Flow Peer Comparison
Competitive Free Cash Flow Analysis
Latest Figures & CAGR of Competitors
Company | Free Cash Flow | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Pulse Biosciences Inc
NASDAQ:PLSE
|
Free Cash Flow
-$36.3m
|
CAGR 3-Years
1%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
N/A
|
|
Becton Dickinson and Co
NYSE:BDX
|
Free Cash Flow
$3B
|
CAGR 3-Years
-10%
|
CAGR 5-Years
9%
|
CAGR 10-Years
9%
|
|
Boston Scientific Corp
NYSE:BSX
|
Free Cash Flow
$1.7B
|
CAGR 3-Years
8%
|
CAGR 5-Years
102%
|
CAGR 10-Years
8%
|
|
Stryker Corp
NYSE:SYK
|
Free Cash Flow
$2.9B
|
CAGR 3-Years
2%
|
CAGR 5-Years
7%
|
CAGR 10-Years
6%
|
|
Abbott Laboratories
NYSE:ABT
|
Free Cash Flow
$4.9B
|
CAGR 3-Years
-14%
|
CAGR 5-Years
2%
|
CAGR 10-Years
9%
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Free Cash Flow
$595.8m
|
CAGR 3-Years
-23%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
-1%
|
See Also
What is Pulse Biosciences Inc's Free Cash Flow?
Free Cash Flow
-36.3m
USD
Based on the financial report for Mar 31, 2024, Pulse Biosciences Inc's Free Cash Flow amounts to -36.3m USD.
What is Pulse Biosciences Inc's Free Cash Flow growth rate?
Free Cash Flow CAGR 5Y
-7%
Over the last year, the Free Cash Flow growth was 5%. The average annual Free Cash Flow growth rates for Pulse Biosciences Inc have been 1% over the past three years , -7% over the past five years .